DE69520475D1 - Pharmaceutical composition of biologically active peptides or proteins - Google Patents

Pharmaceutical composition of biologically active peptides or proteins

Info

Publication number
DE69520475D1
DE69520475D1 DE69520475T DE69520475T DE69520475D1 DE 69520475 D1 DE69520475 D1 DE 69520475D1 DE 69520475 T DE69520475 T DE 69520475T DE 69520475 T DE69520475 T DE 69520475T DE 69520475 D1 DE69520475 D1 DE 69520475D1
Authority
DE
Germany
Prior art keywords
proteins
pharmaceutical composition
biologically active
active peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69520475T
Other languages
German (de)
Other versions
DE69520475T2 (en
Inventor
Makoto Sato
Toshiyuki Kouzaki
Yoko Ishihara
Shigeaki Yoshina
Masanao Nakoshi
Tatsushi Maeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Publication of DE69520475D1 publication Critical patent/DE69520475D1/en
Application granted granted Critical
Publication of DE69520475T2 publication Critical patent/DE69520475T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2214—Motilins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
DE69520475T 1994-07-22 1995-07-10 Pharmaceutical composition of biologically active peptides or proteins Expired - Fee Related DE69520475T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6171070A JPH0827018A (en) 1994-07-22 1994-07-22 Medicinal composition containing physiologically active peptide or protein

Publications (2)

Publication Number Publication Date
DE69520475D1 true DE69520475D1 (en) 2001-05-03
DE69520475T2 DE69520475T2 (en) 2001-09-27

Family

ID=15916480

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69520475T Expired - Fee Related DE69520475T2 (en) 1994-07-22 1995-07-10 Pharmaceutical composition of biologically active peptides or proteins

Country Status (4)

Country Link
US (1) US5733877A (en)
EP (1) EP0706798B1 (en)
JP (1) JPH0827018A (en)
DE (1) DE69520475T2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192319A1 (en) * 1996-09-19 2005-09-01 Albert Boeckh Spot-on formulations for combating parasites
CA2363141C (en) 1999-02-26 2010-04-06 Chiron Corporation Microemulsions with adsorbed macromolecules and microparticles
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
EP1420783A4 (en) * 2001-08-03 2009-09-30 Takeda Pharmaceutical Stable emulsion composition
IL145926A0 (en) 2001-10-15 2002-07-25 Mor Research Applic Ltd Peptide epitopes of mimotopes useful in immunomodulation
US20040077703A1 (en) * 2002-10-02 2004-04-22 Soll Mark D. Nodulisporic acid derivative spot-on formulations for combating parasites
CA2502118A1 (en) 2002-10-11 2004-05-06 Sanwa Kagaku Kenkyusho Co., Ltd. Glp-1 derivatives and transmicosal absorption preparations thereof
IL155136A0 (en) 2003-02-10 2003-10-31 Enzymotec Ltd A composition for reducing blood cholesterol and triglycerides
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
BRPI0418589A (en) * 2003-12-08 2008-01-29 Bentley Pharmaceuticals Inc pharmaceutical compositions and methods for insulin treatment
JP2008509213A (en) * 2004-08-09 2008-03-27 エンジモテック リミテッド Food products for diabetics
WO2006016363A2 (en) 2004-08-10 2006-02-16 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
US8062333B2 (en) * 2005-02-17 2011-11-22 Anpa Medical, Inc. Suture retainer with multiple circumferentially spaced attachment points and suture retention method
US20100129288A1 (en) * 2005-06-28 2010-05-27 Elior Peles Gliomedin, Fragments Thereof and Methods of Using Same
JP2009508517A (en) * 2005-09-22 2009-03-05 コーエン，イルン，アール Immunogenic fragments of T cell receptor constant domains and peptides derived therefrom
WO2008142693A2 (en) * 2007-05-22 2008-11-27 Yeda Research And Development Co. Ltd. Regulation of myelination by nectin-like (necl) molecules
US11559580B1 (en) * 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
EP3211998B1 (en) 2014-10-31 2021-04-07 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal composition comprising fipronil

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564512A (en) * 1978-11-11 1980-05-15 Kanebo Ltd Cosmetic composition of oil-in-water emulsion
JPS609726B2 (en) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 steroid preparations
JPS59216820A (en) 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd Fat emulsion of prostaglandin
GB8416234D0 (en) * 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
JPS61263914A (en) 1985-05-17 1986-11-21 Yutaka Mizushima Lipid microsphere
JPS62284000A (en) 1986-05-31 1987-12-09 Yutaka Mizushima Physiologically active protein bonded lipid microsphere
IT1204400B (en) * 1986-06-20 1989-03-01 Sclavo Spa PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
DE3943519A1 (en) * 1989-04-27 1991-01-17 Stief Georg Treatment of erectile dysfunction - with peptide aspartic-acid -leucine -glutamine -alanine
DE4015108A1 (en) * 1990-05-11 1991-11-14 Leopold Pharma Gmbh STABLE EMULSION FOR APPLICATION OF PHARMACOLOGICALLY ACTIVE ACTIVE SUBSTANCES
US5578323A (en) * 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
EP0580778B1 (en) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Convertible microemulsion formulations
IT1247472B (en) * 1991-05-31 1994-12-17 Fidia Spa PROCESS FOR THE PREPARATION OF MICROSPHERES CONTAINING BIOLOGICALLY ACTIVE COMPONENTS.
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides

Also Published As

Publication number Publication date
US5733877A (en) 1998-03-31
EP0706798B1 (en) 2001-03-28
JPH0827018A (en) 1996-01-30
EP0706798A1 (en) 1996-04-17
DE69520475T2 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
DE69900746D1 (en) CONTROLLED ADMINISTRATION OF PEPTIDES OR PROTEINS
DE69520475D1 (en) Pharmaceutical composition of biologically active peptides or proteins
BR9607317A (en) Peptides and pharmaceutical composition
BR9607318A (en) Peptides and pharmaceutical composition
ZA941771B (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
DE69526801D1 (en) AEROSOL FORMULATIONS WITH PEPTIDES AND PROTEINS
DE69424576D1 (en) BIOLOGICALLY ACTIVE TGF-BETA1 AND TGF-BETA2 PEPTIDES
BR9407583A (en) Processes to produce a mutant bcl-2 protein to identify candidate bcl-2 modulating agents a mutant bcl-2 and mutant bcl-2 proteins and to inhibit the death repressive activity of bcl-2 cells and a mutant bcl-2 polypeptide
AU3321595A (en) Recombinant production of biologically active peptides and proteins
DE3685626T2 (en) SEQUENCING OF PEPTIDES.
DE69132708D1 (en) Therapeutic use of peptides with thrombospondin-like activity
NO964758D0 (en) Use of von Willebrand factor and pharmaceutical preparations
DE69512929D1 (en) SALTS OF AMINO ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE230926T1 (en) SYNERGISTIC MIXTURES OF SELECTED AMINO ACIDS
DK403384A (en) ENTERALLY EFFECTIVE, BIOLOGICALLY ACTIVE PEPTIDE OR PROTEIN AGENTS AND PROCEDURES FOR PRODUCING THEREOF
DE69123345T2 (en) SEQUENTIAL C-DATE DEGRADING OF PEPTIDES AND PROTEINS
DK109590A (en) BIOLOGICAL ACTIVE PROTEIN
BR9604938A (en) Recombinant virus deficient use of this virus pharmaceutical composition and mammalian cell
ATE198469T1 (en) IMPROVED TOLERABILITY OF PHARMACEUTICALLY ACTIVE BETA-AMINO ACIDS
EE9800108A (en) Use of S-100b protein in drugs and drugs containing S-100b protein
NL1000332C1 (en) Gradual chemical modification of biologically active peptides and proteins.
KR950701812A (en) Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease
DE69030316T2 (en) STEP-BY-STEP C-TERMINAL DEGRADATION OF PEPTIDES AND PROTEINS
DE3869939D1 (en) BIOLOGICALLY ACTIVE PEPTIDES.
IT1277338B1 (en) PHARMACEUTICAL COMPOSITIONS OF CYCLOSPORINE OR OTHER PEPTIDE SUBSTANCES

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee